NEW YORK (TheStreet) -- RATINGS CHANGES
Kellogg (K) was downgraded at Morgan Stanley to underweight. Twelve-month price target is $58. Prospects of a recovery are fading, Morgan Stanley said.
Nuvasive (NUVA) was upgraded at Brean Capital to buy from hold. Twelve-month price target is $44. Stock has pulled back, even though fundamentals have improved, Brean Capital said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
This article was written by a staff member of TheStreet.